PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 105 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $32,416 | -67.7% | 14,668 | -62.9% | 0.00% | – |
| Q1 2023 | $100,376 | +217.9% | 39,518 | +134.0% | 0.00% | – |
| Q4 2022 | $31,575 | -12.3% | 16,885 | +20.4% | 0.00% | – |
| Q3 2022 | $36,000 | -83.6% | 14,020 | -68.8% | 0.00% | – |
| Q3 2021 | $219,000 | -64.4% | 44,892 | -50.3% | 0.00% | – |
| Q2 2021 | $616,000 | +422.0% | 90,318 | +442.3% | 0.00% | – |
| Q1 2021 | $118,000 | +11.3% | 16,655 | -1.5% | 0.00% | – |
| Q4 2020 | $106,000 | +41.3% | 16,910 | +22.5% | 0.00% | – |
| Q3 2020 | $75,000 | -56.4% | 13,800 | -58.2% | 0.00% | – |
| Q2 2020 | $172,000 | – | 33,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $36,172,000 | 26.83% |
| Abingworth LLP | 1,301,413 | $18,103,000 | 18.96% |
| Roumell Asset Management, LLC | 290,136 | $4,036,000 | 9.16% |
| Monashee Investment Management LLC | 100,000 | $1,391,000 | 2.19% |
| BVF INC/IL | 575,000 | $7,998,000 | 1.70% |
| Aisling Capital LLC | 482,680 | $6,714,000 | 1.59% |
| Opaleye Management Inc. | 146,700 | $2,041,000 | 1.36% |
| Broadfin Capital, LLC | 803,332 | $11,174,000 | 1.09% |
| GENERAL AMERICAN INVESTORS CO INC | 477,076 | $6,636,000 | 0.69% |
| Opus Point Partners Management, LLC | 37,665 | $524,000 | 0.51% |